Anti-liferative agents comprising substituted benzo[e]pyrido[1,2-a][1,4]diazepines
Grant
US12583857B2
Kind: B2
Mar 24, 2026
Assignee
PHEON THERAPEUTICS LTD
Inventors
Paul Joseph Mark Jackson, David Edwin Thurston, Khondaker Mirazur Rahman
Abstract
The invention relates to substituted pyrridinobenzodiazepines (PDDs) of formula (XVI) and pharmaceutically acceptable salts thereof, which are useful as medicaments, in particular as anti-proliferative agents.
CPC Classifications
A61K 31/551
C07D 487/04
Filing Date
2023-12-21
Application No.
18393274
Claims
18